[1]余正强.保和丸治疗慢性浅表性胃炎的临床疗效及安全性[J].医学信息,2023,36(23):55-58.[doi:10.3969/j.issn.1006-1959.2023.23.013]
 YU Zheng-qiang.Clinical Efficacy and Safety of Baohe Pills in the Treatment of Chronic Superficial Gastritis[J].Journal of Medical Information,2023,36(23):55-58.[doi:10.3969/j.issn.1006-1959.2023.23.013]
点击复制

保和丸治疗慢性浅表性胃炎的临床疗效及安全性()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年23期
页码:
55-58
栏目:
论著
出版日期:
2023-12-01

文章信息/Info

Title:
Clinical Efficacy and Safety of Baohe Pills in the Treatment of Chronic Superficial Gastritis
文章编号:
1006-1959(2023)23-0055-04
作者:
余正强
(金溪县中医院中医内科,江西 金溪 344800)
Author(s):
YU Zheng-qiang
(Internal Medicine Department of Traditional Chinese Medicine,Jinxi County Hospital of Traditional Chinese Medicine,Jinxi 344800,Jiangxi,China)
关键词:
慢性浅表性胃炎保和丸中医症状积分胃肠道症状
Keywords:
Chronic superficial gastritisBaohe pillTraditional Chinese medicine symptom scoreGastrointestinal symptoms
分类号:
R573.3+1
DOI:
10.3969/j.issn.1006-1959.2023.23.013
文献标志码:
A
摘要:
目的 研究保和丸治疗慢性浅表性胃炎(CSG)的临床疗效及安全性。方法 以2019年7月-2022年7月金溪县中医院收治的62例CSG患者为研究对象,按照随机数字表法分为对照组(31例)与观察组(31例)。对照组给予常规西医治疗,观察组在其基础上加用保和丸治疗,比较两组临床疗效、中医症状积分、胃肠道症状分级评分量表(GSRS)、慢性胃炎患者生命质量测定量表(QLICD-CG)评分、不良反应、复发率。结果 观察组治疗总有效率高于对照组(P<0.05);两组治疗后中医症状积分低于治疗前,且观察组中医症状积分低于对照组(P<0.05);两组治疗后GSRS评分低于治疗前,QLICD-CG评分高于治疗前,且观察组GSRS评分低于对照组,QLICD-CG评分高于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05);观察组复发率小于对照组(P<0.05)。结论 保和丸治疗CSG的疗效肯定,可有效改善患者的中医症状积分,缓解其胃肠道症状,提高生活质量,降低复发概率,且用药安全性高。
Abstract:
Objective To study the clinical efficacy and safety of Baohe Pills in the treatment of chronic superficial gastritis (CSG).Methods A total of 62 patients with CSG admitted to Jinxi County Hospital of Traditional Chinese Medicine from July 2019 to July 2022 were divided into control group (31 patients) and observation group (31 patients) according to the random number table method. The control group was treated with conventional western medicine, and the observation group was treated with Baohe pill on the basis of the control group. The clinical efficacy, traditional Chinese medicine symptom score, gastrointestinal symptom rating scale (GSRS), quality of life measurement scale for patients with chronic gastritis (QLICD-CG) score, adverse reactions and recurrence rate were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group (P<0.05). The scores of traditional Chinese medicine symptom symptoms in the two groups after treatment were lower than those before treatment, and the scores of traditional Chinese medicine symptom symptoms in the observation group were lower than those in the control group (P<0.05). After treatment, the GSRS score of the two groups was lower than that before treatment, and the QLICD-CG score was higher than that before treatment, and the GSRS score of the observation group was lower than that of the control group, and the QLICD-CG score was higher than that of the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). The recurrence rate of the observation group was lower than that of the control group (P<0.05).Conclusion Baohe pill is effective in the treatment of CSG, which can effectively improve the TCM symptom score of patients, relieve their gastrointestinal symptoms, improve the quality of life, reduce the probability of recurrence, and has high safety.

参考文献/References:

[1]闫小妮,刘瑜佳,李红霞,等.复方乌贝方治疗慢性浅表性胃炎的疗效及对胃镜像指标、血清EGF、GAS、SS和Hp阴转率的影响[J].四川中医,2019,37(2):116-118.[2]李伟,王小平,蒙立健,等.建中和胃汤治疗脾虚畏寒型慢性浅表性胃炎的疗效及对血清炎性因子的影响[J].中国医药导刊,2019,21(3):157-161.[3]李晓玥,程军,俞仲贤,等.理气合胃方加减结合西医常规疗法治疗幽门螺杆菌阳性慢性浅表性胃炎临床研究[J].国际中医中药杂志,2021,43(10):981-985.[4]乔艳,房玲,杨惠卿,等.慢性浅表性胃炎中医证型分布与幽门螺杆菌感染、胃镜像及病理表现相关性分析[J].安徽中医药大学学报,2021,40(3):26-29.[5]武琛,姬旭,谭海成,等.香砂养胃汤加减结合针刺疗法治疗脾胃虚弱型慢性浅表性胃炎临床疗效及安全性研究[J].辽宁中医杂志,2021,48(8):164-167.[6]曾晓旋,杨晓军.加味健脾疏肝安胃汤合加味胃炎消片治疗脾虚肝郁型慢性浅表性胃炎疗效观察[J].西部中医药,2020,33(12):78-80.[7]王飞,刘姝,杨成俊,等.越鞠保和丸联合盐酸伊托必利片治疗功能性消化不良的疗效分析[J].现代消化及介入诊疗,2021,26(1):93-96.[8]房静远,杜奕奇,刘文忠,等.中国慢性胃炎共识意见(2017年,上海)[J].胃肠病学,2017,22(11):670-687.[9]喻斌,黄陆强,高羽,等.理气暖胃颗粒治疗慢性浅表性胃炎的Ⅳ期临床研究[J].中国临床药理学杂志,2020,36(22):3608-3611.[10]吕翔,丁炜,曹友红.清中汤加味治疗慢性浅表性胃炎脾胃湿热证的疗效观察[J].中医药导报,2020,26(3):85-88.[11]刘梁英,万晓强,石钢,等.阿拉坦五味丸联合泮托拉唑治疗慢性浅表性胃炎的临床研究[J].现代消化及介入诊疗,2020,25(1):83-86.[12]段晓伟,刘卫,贺星,等.温胃舒颗粒联合铝碳酸镁治疗慢性浅表性胃炎的临床研究[J].现代药物与临床,2019,34(6):1761-1764.[13]周士伟,项珊.捏脊联合保和丸治疗小儿积滞的疗效观察[J].中国妇幼保健,2018,33(24):5862-5864.[14]单远莹,郭俊华,孟德荣.越鞠保和丸对慢性阻塞性肺疾病并胃肠功能紊乱患者血清脂联素、尿酸水平及营养状况的影响[J].世界中西医结合杂志,2022,17(6):1177-1181.[15]高雯聪,王永林.荜铃胃痛颗粒联合兰索拉唑治疗慢性浅表性胃炎的临床研究[J].现代药物与临床,2018,33(12):3179-3182.[16]何保军.半夏益中汤对慢性浅表性胃炎患者血清趋化因子、CRP、IL-32水平的影响研究[J].陕西中医,2018,39(5):574-576.[17]徐致君,杨振斌,邱伟,等.白术健脾汤联合耳穴压豆治疗脾胃气虚型慢性浅表性胃炎临床研究[J].山东中医杂志,2018,37(12):992-995.[18]魏华,江楠.香砂六君子汤对浅表性胃炎疗效及其对超氧化物歧化酶和NO的影响[J].世界中医药,2018,13(7):1653-1657.[19]布立影.复方乌贝方与西药三联疗法治疗慢性浅表性胃炎疗效对比分析[J].四川中医,2018,36(7):111-113.[20]杜战国.舒胃愈胆胶囊联合奥美拉唑治疗慢性浅表性胃炎肝胃不和证的疗效观察[J].中国现代应用药学,2018,35(3):419-421.[21]何磊,盛好,雷云霞,等.柴芍六君汤加味对肝脾不和型慢性浅表性胃炎患者SS、MTL、GAS的影响分析[J].中国中西医结合消化杂志,2018,26(6):512-515,519.[22]Shi D,Liu L,Li H,et al.Identifying the molecular basis of Jinhong tablets against chronic superficial gastritis via chemical profile identification and symptom-guided network pharmacology analysis[J].Journal of Pharmaceutical Analysis,2022,12(1):65-76.[23]许少菊,凌晓颖,彭珊珊,等.基于网络药理学探讨平胃散治疗慢性浅表性胃炎的作用机制[J].现代中药研究与实践,2020,34(2):70-74.

相似文献/References:

[1]吴振刚.清金化痰益肺汤合保和丸在肺炎中的应用价值及对肺功能、免疫功能的影响[J].医学信息,2024,37(22):138.[doi:10.3969/j.issn.1006-1959.2024.22.034]
 WU Zhengang.Application Value of Qingjin Huatan Yifei Decoction Combined with Baohe Pill in Treating Pneumonia and its Influence on Lung Function and Immune Function[J].Journal of Medical Information,2024,37(23):138.[doi:10.3969/j.issn.1006-1959.2024.22.034]

更新日期/Last Update: 1900-01-01